GSK will pay up to $3.3 billion to acquire Affinivax, gaining access to its Multiple Antigen Presenting System (MAPS) technology and pneumococcal vaccine candidates.
List view / Grid view
Here, Lucinda Cash-Gibson and Francesco Patalano discuss why the pharmaceutical industry is collaborating to develop protocols for patient-centric integrated platform trials and what the clinical research industry may look like in future.
Growth in the pharmaceutical contract manufacturing market to be driven by advanced technologies, the rising aging population and the increase in chronic disease cases, says report.
Researchers studying the microbiologic diagnosis of pneumonia have identified ways to optimise a pneumonia panel.
A new report has predicted that the global antibiotics market will grow at a CAGR of four percent from 2020-2027.
The portfolio will be offered to low- and lower-middle-income countries to help financially strained healthcare systems care for COVID-19 patients.
According to a recent article, China has approved a number of home-grown vaccines, offering alternatives to global drugmakers' products.
The worldwide trade of the cephalosporin class of antibiotics will increase to $14.1 billion by the end of 2025.
Findings of two phase III, double-blind, randomised clinical trials comparing omadacycline with standard antibiotics have been published in the New England Journal of Medicine
Researchers have found heart complications in patients diagnosed with bacterial pneumonia are more serious than in patients diagnosed with viral pneumonia...
Using AI and machine learning techniques, researchers have developed a new computational tool to screen patients with common retinal diseases, potentially speeding diagnoses and treatment...